Korean J Urol.
2005 Oct;46(10):1094-1097.
Preliminary Study of Tissue Engineered Bladder Regeneration with Poly (epsilon-caprolactone) (PCL) Sheet Seeded with Autologous Muscle-derived Stem Cell
- Affiliations
-
- 1Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
- 2Department of Urology, The Catholic University of Korea, Seoul, Korea. uroljy@catholic.ac.kr
- 3Depratment of Biology, Kyonggi University, Seoul, Korea.
- 4Department of Polymer Science and Engineering, Hannam University, Seoul, Korea.
- 5Department of Biomaterials Research Center, Korea Institute of Science and Technology, Seoul, Korea.
Abstract
-
PURPOSE: To investigate the feasibility of using a poly (epsilon-caprolactone) (PCL) sheet seeded with autologous muscle-derived stem cells as a bladder substitute.
MATERIALS AND METHODS
Muscle-derived stem cells were isolated from the gastrocnemius muscle of 9 female Sprague-Dawley rats using a preplate technique, and cultured on a 5x5mm PCL sheet. The sheets were implanted into the mesentery of the rats in an autologous manner. Three rats were sacrificed 2, 4 and 8 weeks after implantation, and the morphological changes were assessed by H&E and immunofluorescence staining including DAPI, myosin heavy chain (MHC) and choline acetyl transferase (CAT).
RESULTS
All the rats survived for the scheduled time. A mild inflammatory reaction was observed around the PCL sheet in the postoperative 2-week specimen but this receded with time. Muscle cells on the sheet were observed over the experimental period. The 8-week specimen showed a moderate amount of muscle cells on the sheet, and MHC and CAT immunofluorescence staining showed a positive reaction. The muscle layer was not well organized. Angiogenesis was quite noticable between the sheet and the muscle cells on the 8-week specimen.
CONCLUSIONS
A PCL sheet seeded with autologous muscle-derived stem cells showed skeletal muscle differentiation on the sheets 8 weeks after mesenteric implantation in an autologous manner. This suggests the feasibility of using a PCL sheet seeded with autologous muscle-derived stem cell as a bladder substitute.